248 related articles for article (PubMed ID: 29383453)
1. Safety of the concomitant use of methotrexate and a prophylactic dose of trimethoprim-sulfamethoxazole.
Kwon OC; Lee JS; Kim YG; Lee CK; Yoo B; Hong S
Clin Rheumatol; 2018 Dec; 37(12):3215-3220. PubMed ID: 29383453
[TBL] [Abstract][Full Text] [Related]
2. Impact of Prophylactic Trimethoprim-Sulfamethoxazole on Clearance of High-Dose Methotrexate in Adult Patients.
Skoloda D; Newman M; Norman H; Ziggas JE; Ambinder RF
JCO Oncol Pract; 2024 May; 20(5):673-677. PubMed ID: 38382007
[TBL] [Abstract][Full Text] [Related]
3. High daily doses of trimethoprim/sulfamethoxazole are an independent risk factor for adverse reactions in patients with pneumocystis pneumonia and AIDS.
Chang HM; Tsai HC; Lee SS; Kunin C; Lin PC; Wann SR; Chen YS
J Chin Med Assoc; 2016 Jun; 79(6):314-9. PubMed ID: 27025225
[TBL] [Abstract][Full Text] [Related]
4. Tolerability of low-dose sulfamethoxazole/trimethoprim for Pneumocystis jirovecii pneumonia prophylaxis in kidney transplant recipients.
Zmarlicka M; Martin ST; Cardwell SM; Nailor MD
Prog Transplant; 2015 Sep; 25(3):210-6. PubMed ID: 26308779
[TBL] [Abstract][Full Text] [Related]
5. Interaction between trimethoprim-sulfamethoxazole and methotrexate in children with leukemia.
Ferrazzini G; Klein J; Sulh H; Chung D; Griesbrecht E; Koren G
J Pediatr; 1990 Nov; 117(5):823-6. PubMed ID: 2231218
[TBL] [Abstract][Full Text] [Related]
6. Pneumocystis jiroveci pneumonia prophylaxis during maintenance therapy influences methotrexate/6-mercaptopurine dosing but not event-free survival for childhood acute lymphoblastic leukemia.
Levinsen M; Shabaneh D; Bohnstedt C; Harila-Saari A; Jonsson OG; Kanerva J; Lindblom A; Lund B; Andersen EW; Schmiegelow K;
Eur J Haematol; 2012 Jan; 88(1):78-86. PubMed ID: 21854453
[TBL] [Abstract][Full Text] [Related]
7. Pneumocystis pneumonia in patients with rheumatic diseases receiving prolonged, non-high-dose steroids-clinical implication of primary prophylaxis using trimethoprim-sulfamethoxazole.
Park JW; Curtis JR; Kim MJ; Lee H; Song YW; Lee EB
Arthritis Res Ther; 2019 Sep; 21(1):207. PubMed ID: 31521185
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic Trimethoprim-Sulfamethoxazole Does Not Affect Pharmacokinetics or Pharmacodynamics of Methotrexate.
Watts CS; Sciasci JN; Pauley JL; Panetta JC; Pei D; Cheng C; Christensen CM; Mikkelsen TS; Pui CH; Jeha S; Relling MV
J Pediatr Hematol Oncol; 2016 Aug; 38(6):449-52. PubMed ID: 27322715
[TBL] [Abstract][Full Text] [Related]
9. Renal Insufficiency in Concert with Renin-angiotensin-aldosterone Inhibition Is a Major Risk Factor for Hyperkalemia Associated with Low-dose Trimethoprim-sulfamethoxazole in Adults.
Higashioka K; Niiro H; Yoshida K; Oryoji K; Kamada K; Mizuki S; Yokota E
Intern Med; 2016; 55(5):467-71. PubMed ID: 26935365
[TBL] [Abstract][Full Text] [Related]
10. An evaluation of hyperkalemia and serum creatinine elevation associated with different dosage levels of outpatient trimethoprim-sulfamethoxazole with and without concomitant medications.
Gentry CA; Nguyen AT
Ann Pharmacother; 2013 Dec; 47(12):1618-26. PubMed ID: 24259630
[TBL] [Abstract][Full Text] [Related]
11. Methotrexate drug interactions in the treatment of rheumatoid arthritis: a systematic review.
Bourré-Tessier J; Haraoui B
J Rheumatol; 2010 Jul; 37(7):1416-21. PubMed ID: 20436072
[TBL] [Abstract][Full Text] [Related]
12. [Retrospective investigation of side effects and prognoses of moderate-dose trimethoprim-sulfamethoxazole treatment for pneumocystis pneumonia that developed in patients with autoimmune diseases].
Shibata T; Tonooka K; Tsuchida K; Mitomi H; Shibata T; Katsuyama N
Nihon Rinsho Meneki Gakkai Kaishi; 2016; 39(3):213-8. PubMed ID: 27320937
[TBL] [Abstract][Full Text] [Related]
13. Trimethoprim-sulfamethoxazole versus trimethoprim-sulfamethoxazole plus doxycycline as oral eradicative treatment for melioidosis (MERTH): a multicentre, double-blind, non-inferiority, randomised controlled trial.
Chetchotisakd P; Chierakul W; Chaowagul W; Anunnatsiri S; Phimda K; Mootsikapun P; Chaisuksant S; Pilaikul J; Thinkhamrop B; Phiphitaporn S; Susaengrat W; Toondee C; Wongrattanacheewin S; Wuthiekanun V; Chantratita N; Thaipadungpanit J; Day NP; Limmathurotsakul D; Peacock SJ
Lancet; 2014 Mar; 383(9919):807-14. PubMed ID: 24284287
[TBL] [Abstract][Full Text] [Related]
14. Relationship of Sulfamethoxazole Therapeutic Drug Monitoring to Clinical Efficacy and Toxicity: A Retrospective Cohort Study.
Ice LL; Barreto JN; Dao BD; Wolf RC; Dierkhising RA; Jannetto PJ; Langman LJ; Tosh PK
Ther Drug Monit; 2016 Jun; 38(3):319-26. PubMed ID: 26836809
[TBL] [Abstract][Full Text] [Related]
15. A comparison of adverse drug reactions between high- and standard-dose trimethoprim-sulfamethoxazole in the ambulatory setting.
Nguyen AT; Gentry CA; Furrh RZ
Curr Drug Saf; 2013 Apr; 8(2):114-9. PubMed ID: 23713542
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness and safety of lower dose sulfamethoxazole/trimethoprim therapy for Pneumocystis jirovecii pneumonia in patients with systemic rheumatic diseases: A retrospective multicenter study.
Ohmura SI; Naniwa T; Tamechika SY; Miyamoto T; Shichi D; Kazawa N; Iwagaitsu S; Maeda S; Wada JI; Niimi A
J Infect Chemother; 2019 Apr; 25(4):253-261. PubMed ID: 30642768
[TBL] [Abstract][Full Text] [Related]
17. Hyponatremia and/or hyperkalemia in patients treated with the standard dose of trimethoprim-sulfamethoxazole.
Mori H; Kuroda Y; Imamura S; Toyoda A; Yoshida I; Kawakami M; Tabei K
Intern Med; 2003 Aug; 42(8):665-9. PubMed ID: 12924488
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of upfront graded administration of trimethoprim-sulfamethoxazole in systemic lupus erythematosus: A retrospective cohort study.
Suyama Y; Okada M; Rokutanda R; Min C; Sassé B; Kobayashi D; Takahashi O; Deshpande GA; Matsui K; Kawaguchi Y; Kishimoto M
Mod Rheumatol; 2016 Jul; 26(4):557-61. PubMed ID: 26587755
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of prophylaxis for Pneumocystis jirovecii pneumonia involving trimethoprim-sulfamethoxazole dose reduction in kidney transplantation.
Prasad GVR; Beckley J; Mathur M; Gunasekaran M; Nash MM; Rapi L; Huang M; Zaltzman JS
BMC Infect Dis; 2019 Apr; 19(1):311. PubMed ID: 30953458
[TBL] [Abstract][Full Text] [Related]
20. Low-dose trimethoprim-sulfamethoxazole treatment for pneumocystis pneumonia in non-human immunodeficiency virus-infected immunocompromised patients: A single-center retrospective observational cohort study.
Nakashima K; Aoshima M; Nakashita T; Hara M; Otsuki A; Noma S; Misawa M; Otsuka Y; Motojima S
J Microbiol Immunol Infect; 2018 Dec; 51(6):810-820. PubMed ID: 28779879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
